Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Impact of concurrent autoimmune conditions on clinical outcomes and leukaemic transformation in chronic myelomonocytic leukaemia.

Journal of clinical pathology - 17 Apr 2026

Rungjirajittranon Tarinee, Ponvilawan Ben, Sukpanichnant Sanya, Owattanapanich Weerapat

Abstract excerpt

AIMS: Chronic myelomonocytic leukaemia (CMML) is a rare overlap syndrome between myelodysplastic neoplasms and myeloproliferative neoplasms. One distinct associated condition is systemic inflammatory and autoimmune disorders (SIADs). METHODS: We conducted a retrospective cohort study of newly diagnosed CMML patients at our institution between January 2006 and December 2020, comparing those with and without SIADs....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Autoimmune Diseases

Share to Cell Transformation, Neoplastic

Share to Dioxygenases

Share to Leukemia, Myelomonocytic, Chronic

Share to Mutation

Share to Repressor Proteins

Source

Open in PubMed Open full text

Identifiers

PMID: 41781199
DOI: 10.1136/jcp-2025-210517
PMCID: PMC13151462

Genes

ASXL1
NRAS
TET2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Impact of concurrent autoimmune conditions on clinical outcomes and leukaemic transformation in chronic myelomonocytic leukaemia.PMID 41781199Read ↗

Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and managementSemantic proximity Read ↗

Chronic myelomonocytic leukemia: 2022 update on diagnosis, risk stratification, and managementSemantic proximity Read ↗

Spectrum of autoimmune diseases and systemic inflammatory syndromes in patients with chronic myelomonocytic leukemiaSemantic proximity Read ↗

Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and managementSemantic proximity Read ↗

How I diagnose and treat chronic myelomonocytic leukemia.Semantic proximity Read ↗

Chronic myelomonocytic leukemia: 2024 update on diagnosis, risk stratification and management.Semantic proximity Read ↗

Chronic myelomonocytic leukaemia: a concise clinical and pathophysiological reviewSemantic proximity Read ↗

Clinical Features and Genomic Landscape of Myeloproliferative Neoplasm (MPN) Patients with Autoimmune and Inflammatory Diseases (AID)Semantic proximity Read ↗

Chronic Myelomonocytic Leukemia: History, Pathobiology, Diagnostic Controversies, and Evolving Classification.Semantic proximity Read ↗

Inflammation in myelodysplastic syndrome pathogenesis.Semantic proximity Read ↗

Genomic landscape of MDS/CMML associated with systemic inflammatory and autoimmune disease.Semantic proximity Read ↗

[Molecular features of 109 patients with chronic myelomonocytic leukemia in a single center].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.